Medicare’s First Negotiated Price List Is Here

Overview

In this edition of Bloomberg Intelligence’s Votes & Verdicts podcast, Aude Gerspacher, BI’s senior litigation analyst, and Duane Wright, senior health care policy analyst, discuss the first results of the US government’s Medicare price negotiations, its implications and the outlook for the next list of drugs to be negotiated.